National Centre for Neuroimmunology and Emerging Diseases

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

The National Centre for Neuroimmunology and Emerging Disease (NCNED) is an Australian research group led by Sonya Marshall-Gradisnik and Donald Staines.[1]

The NCNED is a part of Griffith University Health, in south-east Queensland.

Potential biomarker[edit]

In February 2016 the research team led by Donald Staines and Sonya Marshall-Gradisnik announced it had created a diagnostic test for the disease using CD8 T cells.[2][3][4][5][6][7][8] The researchers have submitted patent claims in relation to their discovery.[9][10][11]

Professor Sonya Marshall-Gradisnik clarified that 'In response to a number of inquiries of this nature we are pleased to advise that we have both published papers, papers in press, and additional data not for publication, which constitutes commercial-in-confidence'.[12][13]

Notable studies[edit]

Funding[edit]

The NCNED is supported by the Queensland Government and philanthropic donors.[14]

Online presence[edit]

Learn more[edit]

See also[edit]

References[edit]

  1. https://www.griffith.edu.au/health/national-centre-neuroimmunology-emerging-diseases/our-team
  2. Australian scientists make breakthrough in Chronic Fatigue Syndrome testing, ABC News (Australia), 29 February 2016
  3. Griffith Uni claims breakthrough on diagnostic test, #MEAction, February 29, 2016
  4. Screening test for Chronic Fatigue Syndrome on its way, Griffith University, 1 March 2016
  5. A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis’., Journal of Immunology Research, Volume 2016 (2016), Article ID 9064529, 8 pages
  6. New Screening Test for ME/CFS Announced by Griffith University, CFS Treatment Guide, 5 Mar 2016
  7. Chronic fatigue syndrome: new diagnostic tool to speed up treatment and reduce stigma
  8. A screening test for chronic fatigue syndrome is ready for the public
  9. Patent AusPat 2015904991, IP Australia, 2 December 2015
  10. Patent AusPat 2015901567, IP Australia, 1 June 2015
  11. Biological markers - WO 2016023077 A1
  12. Statement from NCNED, Griffith University, 1 March 2016
  13. Letter from Sonya Marshall-Gradisnik, Twitter, 1 March 2016
  14. NCNED Partnerships


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history